Case Reports

The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARS-CoV2 infection and multisystem inflammatory syndrome in children

Department of Clinical Education, St Jude Children’s Research Hospital, Memphis, TN
Department of Pediatrics, Clinical Education, University of Tennessee Health Science Center, Memphis, TN
Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN
Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN; Department of Global Pediatric Medicine, St Jude Children’s Research Hospital, Memphis, TN
Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN
Department of Pediatric Medicine, Division of Critical Care, St Jude Children’s Research Hospital, Memphis, TN
Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN
Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN
Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN
Department of Clinical Education, St Jude Children’s Research Hospital, Memphis, TN
Department of Pediatrics, Division of Cardiology, University of Tennessee Health Science Center, Memphis, TN
Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN
Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children’s Research Hospital, Memphis, TN
Department of Pediatric Medicine, Division of Critical Care, St Jude Children’s Research Hospital, Memphis, TN
Haematologica Early view May 26, 2022 https://doi.org/10.3324/haematol.2022.280603